Ignite Creation Date:
2025-12-25 @ 2:24 AM
Ignite Modification Date:
2025-12-27 @ 5:04 AM
Study NCT ID:
NCT01106534
Status:
COMPLETED
Last Update Posted:
2023-11-14
First Post:
2010-04-16
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
Sponsor:
Abbott Medical Devices
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2009-08
Start Date Type:
None
Primary Completion Date:
2015-02
Primary Completion Date Type:
ACTUAL
Completion Date:
2015-07
Completion Date Type:
ACTUAL
First Submit Date:
2010-04-16
First Submit QC Date:
None
Study First Post Date:
2010-04-20
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2015-07-31
Results First Submit QC Date:
None
Results First Post Date:
2016-06-28
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2015-05-14
Disp First Post Date Type:
ESTIMATED
Last Update Submit Date:
2023-10-27
Last Update Post Date:
2023-11-14
Last Update Post Date Type:
ACTUAL